Last reviewed · How we verify

NCT07510399

Effect of Extracorporeal Radial Shock Wave Ibuprofen Phonophoresis on Subacromial Space in Patients With Impingement Syndrome.

Not yet recruiting NA Last updated 3 April 2026
What this trial tests

NA trial testing radial shock wave phonophoresis plus conventional physical therapy in Rehabilitation in 70 participants. Not yet recruiting.

Timeline
10 March 2026
Primary endpoint
15 May 2026
1 June 2026

Quick facts

Lead sponsorMTI University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment70
Start date10 March 2026
Primary completion15 May 2026
Estimated completion1 June 2026

Drugs / interventions tested

Conditions studied

Sponsor

MTI University

Who can join

Adults 25 to 40, any sex, with Rehabilitation or Shock Wave. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions: does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy. Group (B): Patients will receive shock wave plus conventional Physical therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rehabilitation

Currently open trials in the same condition.

Other MTI University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07510399.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing